SOUTH SAN FRANCISCO, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, today announced that it will participate in an upcoming investor conference in September.

2023年9月5日（GLOBE NEWSWIRE）-Allogene Therapeutics，Inc.（纳斯达克股票代码：ALLO），一家开创异基因CAR T（AlloCAR T™) 今天，癌症产品宣布将于9月参加即将举行的投资者会议。

Baird 2023 Global Healthcare ConferenceTuesday, September 12, 202312:45PM PT/3:45PM ET Any available webcasts will be posted to the Company's website at www.allogene.com under the Investors tab in the News and Events section. Following a live webcast, a replay will be available on the Company's website for approximately 30 days.

Baird 2023 Global Healthcare ConferenceSuday，202312年9月12日下午12:45分PT/3:45分ET任何可用的网络广播将在新闻和活动部分的投资者标签下发布到公司网站www.allogene.com上。在进行实时网络广播之后，将在公司网站上播放约30天。

About Allogene TherapeuticsAllogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) products for cancer. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of “off-the-shelf” CAR T product candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients.

关于Allogene Therapeutics Allogene Therapeutics，总部位于南旧金山，是一家临床阶段的生物技术公司，开创了异基因嵌合抗原受体T细胞（AlloCAR T™) 癌症产品。Allogene由一个在细胞治疗方面拥有丰富经验的管理团队领导，正在开发一系列“现成的”CAR T产品候选产品，目标是按需，更可靠，更大规模地提供现成的细胞治疗。更多的病人。

For more information, please visit www.allogene.com, and follow @AllogeneTx on Twitter and LinkedIn. Cautionary Note on Forward-Looking Statements for AllogeneThis press release contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

有关更多信息，请访问www.allogene.com，并在Twitter和LinkedIn上关注@AllogeneTx。关于Allogenet前瞻性声明的警示本新闻稿包含1995年“私人证券诉讼改革法”安全港规定的前瞻性声明。

The press release may, in some cases, use terms that convey uncertainty of future events or outcomes to identify these forward-looking statements. Forward-looking statements include statements regarding intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: the abilit.

在某些情况下，新闻稿可能会使用表达未来事件或结果不确定性的术语来确定这些前瞻性陈述。前瞻性陈述包括关于意图，信念，预测，前景，分析或当前期望的陈述，其中包括：ABLIT。